Indiana University Melvin and Bren Simon Comprehensive Cancer Center and Winship Cancer Institute of Emory University are Among the Early Adopters of Manifold’s Purpose-Built Platform

印第安纳大学梅尔文和布伦·西蒙综合癌症中心以及埃默里大学温希普癌症研究所是Manifold专门构建平台的早期采用者之一

Manifold, an AI-powered clinical research platform, today announced a $15 million Series A. Led by TQ Ventures, the funding round also includes new investors Calibrate Ventures and SK Ventures, notable founders and CEOs, including healthcare leader Dr. Sachin H. Jain, and existing investors, including TTCER Partners.

人工智能驱动的临床研究平台Manifold今天宣布了一项1500万美元的a系列。由TQ Ventures牵头，这轮融资还包括新投资者Calibrate Ventures和SK Ventures，包括医疗保健领导者Sachin H.Jain博士在内的著名创始人和首席执行官，以及包括TTCER Partners在内的现有投资者。

Built by industry veterans, Manifold’s platform streamlines the manual workflows of modern study and data management. Manifold has already helped research teams reduce the time to insights from months to minutes — a critical metric of research productivity..

Manifold平台由业内资深人士构建，简化了现代研究和数据管理的手动工作流程。Manifold已经帮助研究团队将洞察时间从几个月缩短到几分钟，这是衡量研究生产力的关键指标。。

Legacy workflows can delay research advances that prevent improving patient outcomes by years. Manifold’s AI-powered platform dramatically accelerates modern research studies, enabling researchers to rapidly collect, curate, and analyze comprehensive patient data. As the amount of healthcare data continues to grow and become more complex, an AI-powered technology foundation becomes essential to create a unified, analysis-ready view of each patient’s journey.

传统的工作流程可能会延迟研究进展，从而阻止多年改善患者预后。Manifold的人工智能平台极大地加速了现代研究，使研究人员能够快速收集、整理和分析全面的患者数据。随着医疗保健数据量的不断增长和变得更加复杂，人工智能技术基础对于创建每个患者旅程的统一、可分析视图至关重要。

For the first time, Manifold makes it possible for research teams to enroll and engage study participants, harmonize and curate longitudinal data, find and analyze multimodal datasets, and collaborate securely across organizations — all in one easy-to-use platform..

Manifold首次使研究团队能够招募和参与研究参与者，协调和管理纵向数据，查找和分析多模式数据集，以及跨组织安全合作，所有这些都可以在一个易于使用的平台上实现。。

“Cancer research has had a technology infrastructure problem for years,” said Anna Maria V. Storniolo, MD, Medical Director, Biospecimen Collection and Banking Core at IU Melvin and Bren Simon Comprehensive Cancer Center. “As research organizations access more data from EHRs to genetic sequencing to imaging, research datasets are getting larger and more disparate.

IU Melvin和Bren Simon综合癌症中心生物样本收集和银行核心医学主任Anna Maria V.Storniolo医学博士说：“癌症研究多年来一直存在技术基础设施问题。”。“随着研究机构从EHR到基因测序再到成像获取更多数据，研究数据集变得越来越大，也越来越不同。

Researchers lose precious time and resources trying to connect patient data from these disparate systems into a unified patient view. Our partnership with Manifold on a modern technology infrastructure is enabling us to respond to far more research requests with less manual effort and cost.”.

研究人员试图将这些不同系统的患者数据连接到统一的患者视图中，这会浪费宝贵的时间和资源。我们与Manifold在现代技术基础设施上的合作关系使我们能够以更少的人力和成本响应更多的研究请求。”。

Manifold’s technology has already shown promising results in early collaborations with the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Winship Cancer Institute of Emory University, and more. One research organization unified over 11 terabytes of multimodal data – which spans 1.5 million patients – into a single platform, streamlining study and data operations, increasing research output, and unlocking opportunities for collaboration at scale..

在与印第安纳大学梅尔文和布伦·西蒙综合癌症中心、埃默里大学温希普癌症研究所等机构的早期合作中，歧管的技术已经显示出令人鼓舞的成果。一个研究组织将跨越150万患者的超过11TB的多模式数据整合到一个平台上，简化了研究和数据操作，增加了研究产出，并为大规模合作提供了机会。。

“Manifold is transforming clinical research by providing research organizations with purpose-built technology infrastructure for this new era,” said Vinay Seth Mohta, Co-Founder and CEO at Manifold. “Our vision is to make it ten times faster and one-tenth the cost to conduct modern research studies that unlock insights never before possible.”.

Manifold联合创始人兼首席执行官维奈·塞思·莫塔（VinaySethMohta）表示：“Manifold通过为研究组织提供专门构建的技术基础设施，正在改变临床研究。”。“我们的愿景是使进行现代研究的速度提高十倍，成本降低十分之一，从而释放前所未有的洞察力。”。

Additional investors and advisors include Dr. Gaurav Singal, former Chief Data Officer at Foundation Medicine; Eric Just, former SVP and General Manager at Health Catalyst; Amar Kendale, former Chief Product Officer at Livongo/Teladoc; Andrew Bialecki, Co-Founder and CEO at Klaviyo; Brad Porter, Founder and CEO at Collaborative Robotics and former VP Robotics at Amazon; Steve Fredette, Co-Founder and President at Toast; Jon Karlen, Founder and Chairman at Acadian Software; and Pravin Soni, former CTO and Co-Founder at Elevation Pharma..

其他投资者和顾问包括基金会医学前首席数据官Gaurav Singal博士；Eric Just，Health Catalyst前高级副总裁兼总经理；利文戈/特拉多克公司前首席产品官阿马尔·肯代尔（AmarKendale）；安德鲁·比亚莱基（AndrewBialecki），Klaviyo联合创始人兼首席执行官；Brad Porter，Collaborative Robotics创始人兼首席执行官，亚马逊前机器人副总裁；Toast联合创始人兼总裁SteveFredette；阿卡迪亚软件公司创始人兼董事长乔恩·卡伦；以及Elevation Pharma前首席技术官兼联合创始人Pravin Soni。。

“Manifold is tackling new challenges created by big data increasingly available about every patient,” said Andrew Marks, Co-Founder and Managing Partner at TQ Ventures. “In doing that, they are greatly improving productivity in clinical research today and also laying the groundwork for an industry cloud for personalized medicine in the future.”.

TQ Ventures联合创始人兼管理合伙人安德鲁·马克斯（AndrewMarks）表示：“歧管正在应对每个患者越来越多的大数据带来的新挑战。”。“通过这样做，他们今天大大提高了临床研究的生产力，也为未来的个性化医疗行业云奠定了基础。”。

For more information on Manifold, visit manifold.ai.

有关歧管的更多信息，请访问Manifold.ai。

About Manifold

关于歧管

Manifold is an AI-powered clinical research platform. We streamline the manual workflows of modern study and data management, enabling researchers to do more high-impact research and collaborations with fewer resources. Manifold works with research organizations across the country such as Indiana University Melvin and Bren Simon Comprehensive Cancer Center and Winship Cancer Institute at Emory University.

Manifold是一个人工智能驱动的临床研究平台。我们简化了现代研究和数据管理的手动工作流程，使研究人员能够用更少的资源进行更具影响力的研究和合作。Manifold与全国各地的研究机构合作，如印第安纳大学梅尔文和布伦·西蒙综合癌症中心以及埃默里大学温希普癌症研究所。

Our vision is to make it ten times faster and one-tenth the cost to conduct modern research studies that unlock insights never before possible. For more information, visit us here, or follow us on LinkedIn..

我们的愿景是使进行现代研究的速度提高十倍，成本降低十分之一，从而释放前所未有的洞察力。有关更多信息，请访问我们这里，或在LinkedIn上关注我们。。

Originally announced April 4th, 2024

最初于2024年4月4日宣布

TagsAcadian Software Amar Kendale Amazon Andrew Bialecki Andrew Marks Anna Maria V. Storniolo Brad Porter Calibrate Ventures Collaborative Robotics Dr. Gaurav Singal Dr. Sachin H. Jain Elevation Pharma Eric Just Health Catalyst Health IT Funding Health IT Fundings Health IT Investment IU Melvin and Bren Simon Comprehensive Cancer Center Jon Karlen Klaviyo Livongo Manifold Pravin Soni SK Ventures Steve Fredette Teladoc Toast TQ Ventures TTCER Partners Vinay Seth Mohta .

TagsAcadian软件Amar Kendale Amazon Andrew Bialecki Andrew Marks Anna Maria V.Storniolo Brad Porter Calibrate Ventures Collaborative Robotics Dr.Gaurav Singal Dr.Sachin H.Jain Elevation Pharma Eric Just Health Catalyst Health IT Funding Health IT Investment IU Melvin and Bren Simon Comprehensive Cancer Center Jon Karlen Klaviyo Livongo Manifold Pravin Soni SK Ventures Steve Fredette Teladoc Toast TQ Vent。

Get Fresh Healthcare & IT Stories Delivered Daily

每天提供新鲜的医疗保健和IT故事

Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter.

加入成千上万订阅我们每日新闻稿的healthcare&HealthIT同行。

We respect your privacy and will never sell or give out your contact information

我们尊重您的隐私，绝不出售或泄露您的联系信息